- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- March 2025
- 197 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 492 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 197 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 144 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- January 2025
- 141 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- March 2023
- 71 Pages
Global
€2662EUR$2,800USD£2,236GBP
- Report
- January 2023
- 116 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- February 2024
- 131 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 113 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 104 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2024
- 112 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2024
- 151 Pages
Global
From €3500EUR$3,944USD£3,043GBP

The Oral Thin Film (OTF) market is a subset of the drug delivery industry. OTFs are thin, flexible films that dissolve quickly in the mouth and deliver drugs to the bloodstream. They are an attractive alternative to traditional oral dosage forms such as tablets and capsules, as they are easier to swallow and can be customized to deliver a variety of drugs. OTFs also offer improved bioavailability, faster onset of action, and improved patient compliance.
OTF technology is being used to develop treatments for a wide range of conditions, including pain, allergies, and mental health disorders. The market is expected to grow in the coming years, driven by increasing demand for more convenient and effective drug delivery systems.
Some of the major players in the OTF market include Novartis, Pfizer, GlaxoSmithKline, Merck, and Johnson & Johnson. Other companies in the market include Aquestive Therapeutics, Acorda Therapeutics, and Zydus Cadila. Show Less Read more